Axiogenesis   The company is an innovative and productive biotechnology company located in Cologne, Germany. Its primary focus is to develop novel assays that use differentiated embryonic stem cell (ES) and induced pluripotent stem cell (iPS) derived cell types that display normal physiological behavior. These cells are used in pharmacology and safety screening in the pharmaceutical, chemical, and cosmetics industries. The assays detect the efficacy or toxicity of new and existing drugs and chemicals on the developing embryo and differentiated functional tissue.